HB 533 Alabama House · 2026 Regular Session

Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

This bill expands the types of single-dose epinephrine devices that schools and authorized entities in Alabama are permitted to carry and use to treat life-threatening allergic reactions. Currently, only specific autoinjector devices are approved for student self-administration and school stockpiling, but this legislation would allow any FDA-approved premeasured single-dose epinephrine system to be used for this purpose. The changes apply to public and nonpublic schools, school staff, and students who have received proper medical authorization and training for self-administration. The bill also maintains existing protections that shield schools and trained personnel from liability when following established protocols for emergency response to allergic reactions.

Issues: ✓ Education ✓ Healthcare

Bill status signed all 5 stages cleared

Introduction

Mar 2026

Committee Review

Apr 2026

House Passage

Mar 2026

Senate Passage

Apr 2026

Signed into Law

Apr 2026

Introduced Mar 3, 2026 Signed Apr 17, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Introduced → Enrolled · 4 edits · Apr 17, 2026

MODERATE

The bill was finalized as an enrolled act, updating the bill identifier and page headers to reflect its official status. Substantively, the text of the law was expanded to include more detailed requirements for medical authorization forms, clarifying that students may possess controlled substances if permitted by the curriculum, and defining epinephrine delivery systems to include FDA-approved premeasured devices beyond just autoinjectables.

Scope change

The scope of the bill's applicability remains focused on public and nonpublic schools in Alabama regarding student medication self-administration, but the specific rules and definitions governing approved medications and authorization forms were broadened and clarified.

REQUIREMENT

The required medical authorization form was expanded to include specific details such as the name, purpose, and dosage of medications, frequency of administration, special instructions, and prescription duration.

DEFINITION

A formal definition was added for 'single dose autoinjectable epinephrine delivery system,' clarifying that it includes any FDA-approved premeasured device used to treat life-threatening allergic reactions.

ELIGIBILITY

The bill explicitly clarifies that students are permitted to possess controlled substances on school property if the medication curriculum allows it, removing previous ambiguity.

TECHNICAL

The bill number was updated from 'Introduced' to 'Enrolled,' and the internal document identifier was changed from EJILI92-1 to EJILI92-2 to reflect the final legislative version.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 8, 2026

Upper · Passed

Motion to Read a Third Time and Pass - Adopted Roll Call 1271

upper

Apr 1, 2026

Upper · Passed

Reported Out of Committee Second House

upper

Mar 31, 2026

Upper · Passed

Pending Committee Action in Second House (Healthcare)

upper

Mar 17, 2026

Lower · Passed

Motion to Read a Third Time and Pass - Adopted Roll Call 966

lower

Mar 11, 2026

Lower · Passed

Reported Out of Committee House of Origin

lower

Mar 3, 2026

Lower · Passed

Pending Committee Action in House of Origin (Health)

lower

1 primary · 0 co-sponsors